Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
ORIA was delisted on the 28th of April, 2023.
35 hedge funds and large institutions have $112M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2021 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
400% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 2
30% more capital invested
Capital invested by funds: $86.2M → $112M (+$26.1M)
30% more funds holding
Funds holding: 27 → 35 (+8)
33% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
+$6.23M |
| 2 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$5.88M |
| 3 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$5.13M |
| 4 |
KC
Kepos Capital
New York
|
+$4.91M |
| 5 |
Millennium Management
New York
|
+$2.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$130K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$109K |
| 3 |
EAM
Exos Asset Management
New York
|
-$38.9K |
| 4 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
-$6.17K |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
-$6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
26
CVI Holdings
Wilmington,
Delaware
| $967K | – | – | – |
|
|
AFM
27
Anson Funds Management
Dallas,
Texas
| $725K | – | – | – |
|
|
WA
28
Whitebox Advisors
Minneapolis,
Minnesota
| $725K | – | – | – |
|
|
EAM
29
Exos Asset Management
New York
| $494K | -$38.9K | -3,963 | -7% |
|
|
LOAMU
30
Lombard Odier Asset Management (USA)
New York
| $484K | +$491K | +50,000 | New |
|
31
Bank of Nova Scotia
Toronto,
Ontario, Canada
| $387K | +$393K | +40,000 | New |
|
|
FLC
32
Fifth Lane Capital
Austin,
Texas
| $324K | +$329K | +33,500 | New |
|
|
HF
33
HRT Financial
New York
| $196K | +$196K | +20,000 | New |
|
|
PAM
34
Panagora Asset Management
Boston,
Massachusetts
| – | -$130K | -13,480 | Closed |
|
|
WAM
35
Wolverine Asset Management
Chicago,
Illinois
| – | -$6K | -706 | Closed |
|
|
TRCT
36
Tower Research Capital (TRC)
New York
| – | +$20 | +2 | New |
|
ORIA Hedge Fund Activity: Q4 2021 in Review
35 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) for Q4 2021, worth a combined $112M — up 30% from $86.2M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new ORIA positions and 2 closed out — a net gain of 8 holders — while 2 added to existing stakes and 3 trimmed.
The largest buyer was Cubist Systematic Strategies, opening a new position worth an estimated $6.23M. The largest seller was Panagora Asset Management, exiting entirely with an estimated $130K sold.
- 35 institutional investors held Orion Biotech Opportunities Corp. Class A Ordinary Share (ORIA) as of Q4 2021, up from 27 in Q3 2021.
- Funds reported $112M of Orion Biotech Opportunities Corp. Class A Ordinary Share stock for Q4 2021, up 30% quarter-over-quarter.
- 10 funds opened new Orion Biotech Opportunities Corp. Class A Ordinary Share positions in Q4 2021 and 2 closed out, a net change of +8 holders.
- The largest Orion Biotech Opportunities Corp. Class A Ordinary Share buyer in Q4 2021 was Cubist Systematic Strategies, an estimated $6.23M added.
- The largest Orion Biotech Opportunities Corp. Class A Ordinary Share seller in Q4 2021 was Panagora Asset Management, an estimated $130K sold.
Based on aggregated 13F filings for Q4 2021.